Sage Journals: Discover world-class research

Retricted access

Brief report

First published 2004-7

FTY720 and Cyclosporine: Evaluation for a Pharmacokinetic Interaction

John M Kovarik, Robert L Schmouder, Denise Barilla [...]

Annals of Pharmacotherapy

Retricted access

Research article

First published 1998-7

Effect of a New Immunosuppressive Agent,Fty720,on Survival of Islet Allografts

Toru Yamasaki, Kazutomo Inoue, Hiroyuki Hayashi [...]

Cell Transplantation

Open access

Research article

First published 2020

A Pilot Microbiota Study in Parkinson’s Disease Patients versus Control Subjects,and Effects of FTY720 and FTY720-Mitoxy Therapies in Parkinsonian and Multiple System Atrophy Mouse Models

Guadalupe Vidal-Martinez, Brandon Chin, Cynthia Camarillo [...]

Journal of Parkinson’s Disease

Retricted access

Research article

First published 2012-3

FTY720 on the way from the base camp to the summit of the mountain: relevance for remyelination

M Kipp, S Amor

Multiple Sclerosis Journal

Open access

Research article

First published 2024-09-27

The Effect of FTY720 on Sphingolipid Imbalance and Cognitive Decline in Aged EFAD Mice

Qian Luo, Simone M. Crivelli, Shenghua Zong [...]

Journal of Alzheimer's Disease Reports

Open access

Research article

First published 2021

FTY720 Improves the Survival of Autologous Fat Grafting by Modulating Macrophages Toward M2 Polarization Via STAT3 Pathway

Yi Yi, Weijie Hu, Wenchang Lv [...]

Cell Transplantation

Free access

Research article

First published 2012-4

Oral FTY720 Administration Induces Immune Tolerance and Inhibits Early Development of Atherosclerosis in Apolipoprotein E-Deficient Mice

K. Huang, S.Q. Li, W.J. Wang [...]

International Journal of Immunopathology and Pharmacology

Open access

Research article

First published 2020-1

Sphingosine-1-phosphate receptor-independent lung endothelial cell barrier disruption induced by FTY720 regioisomers

Sara M. Camp, Alexander Marciniak, Eddie T. Chiang [...]

Pulmonary Circulation

Open access

Research article

First published 2007

FTY720 Story. Its Discovery and the following Accelerated Development of Sphingosine 1-Phosphate Receptor Agonists as Immunomodulators Based on Reverse Pharmacology

Kunitomo Adachi, Kenji Chiba

Perspectives in Medicinal Chemistry

Retricted access

Other

First published 2010-02

Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results

G. Comi, P. O'Connor, X. Montalban [...]

Multiple Sclerosis Journal

Search results